NEW YORK (GenomeWeb) – Illumina and Cornell University have jointly agreed to dismiss a patent dispute that originated in 2010, according to documents filed with the US District Court for the District of Delaware.

Cornell and Life Technologies (now part of Thermo Fisher Scientific) sued Illumina in May 2010, claiming that Illumina's microarray products infringed on eight patents held by Cornell and exclusively licensed to Life Tech.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.